Is there currently any ongoing dialogue or interest from potential commercial partners or academic partners to bring TG into clinical trials in Europe and the U.S.?
And yes, we have discussions. We don’t want to sort of speculate too much, but there are both discussions with academic and commercial partners for TG in Europe and the U.S.
https://finance.yahoo.com/news/edited-transcript-trvx-ol-earnings-104231503.html